|
|
1 drop, topical, every 5–6 hr
|
|
|
|
1 drop, topical, every 1–2 hr
|
|
|
|
1 drop, topical, every 2 hr initially (2 days), then 3–8 times daily
|
Ocular herpesvirus infection
|
|
|
0.4–1 cm ointment, topical, every 5–6 hr; 3–6 times daily
|
Ocular herpesvirus infection
|
|
200 mg/mL suspension for injection
|
10–30 mg/kg/day, IV, as CRI for 12–24 hr
|
|
|
200-mg capsules or tablets
|
200 mg, PO, qid, every 4 hr, or 5 times daily
|
|
|
|
Cover lesion, topical, every 3 hr, 6 times daily
|
|
|
|
80 mg/kg/day (mixed with peanut butter), PO, for 7–14 days
|
Pacheco’s disease in birds
|
|
|
250–500 mg/m2, IV, tid, infused over at least 1 hr
|
|
|
|
|
|
|
|
11 mg/kg/day, IV, for 7 days
|
Susceptible viral infections
|
|
|
Using SPAC-2 nebulizer only, inhalation, 8–18 hr period daily
|
|
|
10 mg/mL syrup; 10 mg/mL injection
|
5–20 mg/kg (cats), PO or SC, bid-tid
|
|
|
|
100 mg total (human), PO, once to twice daily
|
|
|
|
100 mg/day total (juveniles), PO
|
|
|
|
200–300 mg/day total (human), PO
|
|
|
|
3 × 106 IU/person/day, SC, IM; 0.5–5 U/kg/day, PO; 100,000 U/kg/day, SC
|
|
|
|
|
|
|
|
15–30 U, PO, IM, SC, once daily on alternate weeks
|
|